Literature DB >> 8146140

Quest for life-long protection by vaccination.

W R Dowdle1, W A Orenstein.   

Abstract

Life-long protection from disease through immunization can be accomplished through individual or community protection. Individual protection is the goal for vaccination against diseases that have inanimate or animal reservoirs or that pose risks for certain populations. Community protection is the goal for vaccination against diseases that are transmitted only from human to human. Community protection afforded by childhood vaccines has been highly successful against measles, rubella, mumps, and polio. However, outbreaks of measles, rubella, and mumps continue to occur, primarily because of inadequate immunization of children under age 2. Simplification of vaccination regimens, provision of incentives to care providers and parents, and increased access to care should improve vaccination rates in the United States. Better protection requires better use of available vaccines. Eradication of disease through vaccination is the ultimate goal of community protection. Elimination of the infectious agent is the most effective means of achieving life-long protection. The World Health Organization's (WHO) smallpox eradication campaign eliminated a serious disease as well as the need for a vaccine with frequent and severe adverse reactions. The discontinuation of smallpox vaccination in the United States has produced a savings of over $3 billion. Polio has been targeted by WHO for eradication by the year 2000. The eradication of polio and the elimination of the need for polio vaccination in the United States should result in a savings of $110 million per year in vaccine costs alone. Strong United States support is crucial for WHO to reach its goal. Any of the vaccine-preventable childhood virus diseases could be eradicated with sufficient national and international will. Measles and hepatitis B should be high priorities. The ultimate goal of vaccination is life-long protection of all individuals. Any disease of sufficient public health importance to warrant routine vaccination is of sufficient importance to warrant eradication wherever judged to be possible.

Entities:  

Mesh:

Year:  1994        PMID: 8146140      PMCID: PMC43389          DOI: 10.1073/pnas.91.7.2464

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Strategies for the global eradication of poliomyelitis by the year 2000.

Authors:  P F Wright; R J Kim-Farley; C A de Quadros; S E Robertson; R M Scott; N A Ward; R H Henderson
Journal:  N Engl J Med       Date:  1991-12-19       Impact factor: 91.245

2.  Developments in pertussis immunisation in Japan.

Authors:  M Kimura; H Kuno-Sakai
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

3.  The case for global eradication of poliomyelitis.

Authors:  A R Hinman; W H Foege; C A de Quadros; P A Patriarca; W A Orenstein; E W Brink
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

4.  Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia.

Authors:  H C Whittle; H Inskip; A J Hall; M Mendy; R Downes; S Hoare
Journal:  Lancet       Date:  1991-03-30       Impact factor: 79.321

Review 5.  The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study.

Authors:  J D Cherry
Journal:  Curr Probl Pediatr       Date:  1984-02

6.  World eradication of measles.

Authors:  A R Hinman
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

Review 7.  Eradication of poliomyelitis: progress in the Americas.

Authors:  C A De Quadros; J K Andrus; J M Olivé; C M Da Silveira; R M Eikhof; P Carrasco; J W Fitzsimmons; F P Pinheiro
Journal:  Pediatr Infect Dis J       Date:  1991-03       Impact factor: 2.129

8.  Measles herd immunity. The association of attack rates with immunization rates in preschool children.

Authors:  T L Schlenker; C Bain; A L Baughman; S C Hadler
Journal:  JAMA       Date:  1992-02-12       Impact factor: 56.272

9.  Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists.

Authors:  G R Noble; R H Bernier; E C Esber; M C Hardegree; A R Hinman; D Klein; A J Saah
Journal:  JAMA       Date:  1987-03-13       Impact factor: 56.272

10.  Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program.

Authors:  Y J Tsen; M H Chang; H Y Hsu; C Y Lee; J L Sung; D S Chen
Journal:  J Med Virol       Date:  1991-06       Impact factor: 2.327

View more
  3 in total

1.  Smallpox: residual antibody after vaccination.

Authors:  Stephanie Gallwitz; Ted Schutzbank; Richard L Heberling; S S Kalter; Jeffrey E Galpin
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic.

Authors:  Patricia Kaaijk; Sigrid Gouma; Hinke I Hulscher; Wanda G Han; Deborah E Kleijne; Rob S van Binnendijk; Cécile A van Els
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  The Binding Landscape of Serum Antibodies: How Physical and Mathematical Concepts Can Advance Systems Immunology.

Authors:  József Prechl; Krisztián Papp; Ágnes Kovács; Tamás Pfeil
Journal:  Antibodies (Basel)       Date:  2022-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.